Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Jazz Pharmaceuticals plc JAZZ

Full chart Compare
Set alert

Price alert · JAZZ

All alert types
234.66 USD +4.92 (+2.14%)

At closeNov 4, 2026, 4:00 PM EST

234.66 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

228.45 Day range 234.67
128.80 52-week range 266.38
YTD
+38.04%
1 year
+70.27%

Financial health

Altman Z-Score

1.93 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 5
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -29.1×
FY 2016: 16.6×FY 2017: 16.6×FY 2018: 16.6×FY 2019: 16.2×FY 2020: 38.6×FY 2021: -23.1×FY 2022: -44.5×FY 2023: 18.8×FY 2024: 13.6×FY 2025: -29.1×
FY 2016 5y median -23.1× FY 2025
P/S 2.4×
FY 2016: 4.4×FY 2017: 5.0×FY 2018: 3.9×FY 2019: 3.9×FY 2020: 3.9×FY 2021: 2.5×FY 2022: 2.7×FY 2023: 2.0×FY 2024: 1.9×FY 2025: 2.4×
FY 2016 5y median 2.4× FY 2025
P/B 2.4×
FY 2016: 3.5×FY 2017: 3.0×FY 2018: 2.7×FY 2019: 2.7×FY 2020: 2.5×FY 2021: 1.9×FY 2022: 3.2×FY 2023: 2.1×FY 2024: 1.9×FY 2025: 2.4×
FY 2016 5y median 2.1× FY 2025
P/FCF 9.0×
FY 2016: 16.1×FY 2017: 14.0×FY 2018: 11.1×FY 2019: 14.3×FY 2020: 17.7×FY 2021: 10.4×FY 2022: 12.9×FY 2023: 7.3×FY 2024: 5.7×FY 2025: 9.0×
FY 2016 5y median 9.0× FY 2025
EV/EBITDA 54.8×
FY 2016: 11.0×FY 2017: 11.9×FY 2018: 9.4×FY 2019: 9.5×FY 2020: 10.0×FY 2021: 12.8×FY 2022: 10.1×FY 2023: 8.3×FY 2024: 7.5×FY 2025: 54.8×
FY 2016 5y median 10.1× FY 2025
EV/Sales 3.4×
FY 2016: 5.6×FY 2017: 5.7×FY 2018: 4.6×FY 2019: 4.4×FY 2020: 4.4×FY 2021: 4.3×FY 2022: 4.1×FY 2023: 3.1×FY 2024: 2.8×FY 2025: 3.4×
FY 2016 5y median 3.4× FY 2025
FCF Yield 11.1%
FY 2016: 6.2%FY 2017: 7.2%FY 2018: 9.0%FY 2019: 7.0%FY 2020: 5.7%FY 2021: 9.6%FY 2022: 7.8%FY 2023: 13.7%FY 2024: 17.7%FY 2025: 11.1%
FY 2016 5y median 11.1% FY 2025

Profitability

Gross Margin 88.2%
FY 2016: 92.9%FY 2017: 93.2%FY 2018: 93.6%FY 2019: 94.1%FY 2020: 93.7%FY 2021: 85.8%FY 2022: 85.2%FY 2023: 88.6%FY 2024: 89.0%FY 2025: 88.2%
FY 2016 5y median 88.2% FY 2025
Operating Margin 5.3%
FY 2016: 39.8%FY 2017: 32.7%FY 2018: 32.5%FY 2019: 24.6%FY 2020: 16.0%FY 2021: 5.5%FY 2022: -1.8%FY 2023: 15.1%FY 2024: 17.6%FY 2025: 5.3%
FY 2016 5y median 5.5% FY 2025
Net Margin -8.3%
FY 2016: 26.7%FY 2017: 30.1%FY 2018: 23.6%FY 2019: 24.2%FY 2020: 10.1%FY 2021: -10.6%FY 2022: -6.1%FY 2023: 10.8%FY 2024: 13.8%FY 2025: -8.3%
FY 2016 5y median -6.1% FY 2025
ROE -8.2%
FY 2016: 21.1%FY 2017: 18.0%FY 2018: 16.2%FY 2019: 16.8%FY 2020: 6.5%FY 2021: -8.3%FY 2022: -7.3%FY 2023: 11.1%FY 2024: 13.7%FY 2025: -8.2%
FY 2016 5y median -7.3% FY 2025
ROIC 1.2%
FY 2016: 9.6%FY 2017: 10.9%FY 2018: 10.7%FY 2019: 10.2%FY 2020: 5.4%FY 2021: 1.5%FY 2022: -0.4%FY 2023: 5.5%FY 2024: 6.5%FY 2025: 1.2%
FY 2016 5y median 1.5% FY 2025
ROA -3.1%
FY 2016: 8.3%FY 2017: 9.5%FY 2018: 8.6%FY 2019: 9.4%FY 2020: 3.7%FY 2021: -2.7%FY 2022: -2.1%FY 2023: 3.6%FY 2024: 4.7%FY 2025: -3.1%
FY 2016 5y median -2.1% FY 2025

Growth (YoY)

Revenue 4.9%
FY 2016: 12.3%FY 2017: 8.8%FY 2018: 16.8%FY 2019: 14.3%FY 2020: 9.3%FY 2021: 30.9%FY 2022: 18.3%FY 2023: 4.8%FY 2024: 6.1%FY 2025: 4.9%
FY 2016 FY 2025
Operating Income -68.7%
FY 2016: 16.4%FY 2017: -10.6%FY 2018: 16.3%FY 2019: -13.4%FY 2020: -29.0%FY 2021: -55.0%FY 2022: -138.5%FY 2023: 983.0%FY 2024: 23.9%FY 2025: -68.7%
FY 2016 FY 2025
EPS (diluted) -167.5%
FY 2016: 22.6%FY 2017: 24.2%FY 2018: -8.3%FY 2019: 24.5%FY 2020: -53.6%FY 2021: -230.6%FY 2022: 35.0%FY 2023: 270.4%FY 2024: 41.8%FY 2025: -167.5%
FY 2016 FY 2025
Free Cash Flow -15.0%
FY 2016: -17.5%FY 2017: 41.6%FY 2018: 15.2%FY 2019: -11.0%FY 2020: -12.4%FY 2021: 40.9%FY 2022: 5.6%FY 2023: 38.0%FY 2024: 26.2%FY 2025: -15.0%
FY 2016 FY 2025

Financial Health

Current Ratio 1.9×
FY 2016: 2.9×FY 2017: 3.3×FY 2018: 3.6×FY 2019: 4.5×FY 2020: 4.3×FY 2021: 3.2×FY 2022: 2.8×FY 2023: 2.2×FY 2024: 4.5×FY 2025: 1.9×
FY 2016 5y median 2.8× FY 2025
Quick Ratio 1.7×
FY 2016: 2.8×FY 2017: 3.1×FY 2018: 3.4×FY 2019: 4.3×FY 2020: 4.2×FY 2021: 1.9×FY 2022: 2.0×FY 2023: 1.8×FY 2024: 4.0×FY 2025: 1.7×
FY 2016 5y median 1.9× FY 2025
Debt / Equity 1.3×
FY 2016: 1.1×FY 2017: 0.6×FY 2018: 0.6×FY 2019: 0.6×FY 2020: 0.6×FY 2021: 1.6×FY 2022: 1.9×FY 2023: 1.5×FY 2024: 1.5×FY 2025: 1.3×
FY 2016 5y median 1.5× FY 2025
Net Debt / EBITDA 15.3×
FY 2016: 2.2×FY 2017: 1.5×FY 2018: 1.4×FY 2019: 1.1×FY 2020: 1.1×FY 2021: 5.4×FY 2022: 3.4×FY 2023: 3.0×FY 2024: 2.5×FY 2025: 15.3×
FY 2016 5y median 3.4× FY 2025
Interest Coverage 1.2×
FY 2016: 9.6×FY 2017: 6.8×FY 2018: 7.8×FY 2019: 7.4×FY 2020: 3.8×FY 2021: 0.6×FY 2022: -0.2×FY 2023: 2.0×FY 2024: 3.0×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31